[Skip to Content]
[Skip to Content Landing]
June 2, 1900


JAMA. 1900;XXXIV(22):1420. doi:10.1001/jama.1900.02460220050007

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


When some two months ago The Journal announced its intention to subject the matter of proprietary medicines to a thorough investigation, it realized that the task was a difficult one. While sporadic attempts have been made from time to time, by medical associations and by medical journals, but little progress has been made in checking the evils complained of and, in fact, but little light has so far been shed on the subject. It is believed that this has been primarily due to failure in comprehending the vast scope of such inquiry. The field is so large that nothing short of the most thorough consideration of the entire subject, in all its phases, will be adequate to furnish a basis for such conclusions as may be necessary in determining the status of the various medicinal agents and compounds which the enterprise and genius of foreign and domestic manufacturers are constantly

First Page Preview View Large
First page PDF preview
First page PDF preview